A tetracycline derivative that acts as a protein synthesis inhibitor. It is used as an antibacterial agent for the systemic treatment of complicated skin and intra-abdominal infections. It is also used for the treatment of community-acquired pneumonia.
Tigecycline has been studied across 14 research domains including 🔬 Oncology, ⚡ Energy & Fatigue, 🫘 Kidney, 🧠 Focus & Attention, 😴 Sleep. The primary research focus is 🔬 Oncology with 7% of studies addressing this area.
The following compounds share molecular targets with Tigecycline, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Tigecycline is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.